Disease modification in ankylosing spondylitis

被引：0
|
作者：
Walter P. Maksymowych
机构：
[1] 562 Heritage Medical Research Building,Department of Medicine
[2] University of Alberta,undefined
来源：
Nature Reviews Rheumatology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Any form of treatment for patients with ankylosing spondylitis (AS) is defined as being disease-modifying on the basis of its ability to decrease inflammation, improve function and inhibit the progression of structural damage. This Review outlines clinical outcomes that are relevant to the concept of disease modification, looks at what is known about the disease-modifying properties of currently available agents and considers the challenges involved in developing future therapies for AS.
引用
收藏
页码：75 / 81
页数：6
相关论文
共 50 条
  • [41] Coexisting ankylosing spondylitis and Behcet's disease
    Tosun, M
    Uslu, T
    Imamoglu, HI
    Bahadir, S
    Erdolu, S
    Guler, M
    CLINICAL RHEUMATOLOGY, 1996, 15 (06) : 619 - 620
  • [42] Disease activity and lipid profile in ankylosing spondylitis
    Van Halm, VP
    Van Eek, MCJ
    Van Denderen, JC
    Van de Stadt, RJ
    Van der Horst-Bruinsma, IE
    Dijkmans, BAC
    Nurmohamed, MT
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 396 - 396
  • [43] Metabolic bone disease in a patient with ankylosing spondylitis
    Haq, I
    Sturge, RAS
    Pringle, J
    Keen, RW
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (06) : 1213 - 1213
  • [44] Coexistence of Behcet's Disease and Ankylosing Spondylitis
    Celik, Canan
    Ucan, Halil
    Uckun, Asli Caliskan
    Alemdaroglu, Ebru
    TURKISH JOURNAL OF RHEUMATOLOGY, 2011, 26 (03) : 271 - 272
  • [45] Ankylosing spondylitis is a volatile and variably progressive disease
    Sengupta, Raj
    Sallis, David
    Pomeroy, Emma
    Mogg, Rebecca
    Stone, Millicent A.
    RHEUMATOLOGY, 2008, 47 : II77 - II77
  • [46] BURDEN OF DISEASE ANALYSIS OF ANKYLOSING SPONDYLITIS IN HUNGARY
    Hegyi, R.
    Nagy, B.
    Koncz, A.
    Huybrechts, I
    Lavicky, J.
    Ferenczik, A.
    VALUE IN HEALTH, 2014, 17 (07) : A376 - A377
  • [47] Ankylosing spondylitis: how should the disease be assessed?
    Dougados, M
    van der Heijde, D
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (04): : 605 - 618
  • [48] Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma, J
    Cardon, LR
    Bradbury, L
    Brophy, S
    van der Horst-Bruinsma, I
    Calin, A
    Brown, MA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (06): : 1396 - 1400
  • [49] Effects of Nsaids on Disease Activity in Ankylosing Spondylitis
    Hwang, Mark
    Ranganathan, Prabha
    Lee, MinJae
    Eisen, Seth
    Ward, Michael
    Gensler, Lianne S.
    Brown, Mathew A.
    Jia, Johnathan
    Tahanan, Amirali
    Rahbar, Mohammad H.
    Weisman, Michael
    Reveille, John D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] The coexistence of Behcet's disease and ankylosing spondylitis
    Borman, P
    Bodur, H
    Ak, G
    Bostan, EE
    Barça, N
    RHEUMATOLOGY INTERNATIONAL, 2000, 19 (05) : 195 - 198
12345